{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T13:24:09Z","timestamp":1748352249876},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,9]],"date-time":"2016-01-09T00:00:00Z","timestamp":1452297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Platform for Drug Discovery, Informatics, and Structural Life Science"},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"name":"JSPS KAKENHI","award":["26253077"],"award-info":[{"award-number":["26253077"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jphs.2016.01.002","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T09:58:40Z","timestamp":1452765520000},"page":"64-67","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["P-glycoprotein inhibitors improve effective dose and time of pregabalin to inhibit intermittent cold stress-induced central pain"],"prefix":"10.1016","volume":"131","author":[{"given":"Takehiro","family":"Mukae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wakako","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2016.01.002_bib1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/2042098613505614","article-title":"Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain","volume":"5","author":"Toth","year":"2014","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.jphs.2016.01.002_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pain.2009.05.014","article-title":"Treatment of fibromyalgia syndrome with gabapentin and pregabalin\u2013a meta-analysis of randomized controlled trials","volume":"145","author":"Hauser","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2016.01.002_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","article-title":"Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery","volume":"73","author":"Taylor","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jphs.2016.01.002_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3959(03)00173-8","article-title":"Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C","volume":"105","author":"Fehrenbacher","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2016.01.002_bib5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1124\/mol.106.023309","article-title":"Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons","volume":"70","author":"Micheva","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jphs.2016.01.002_bib6","doi-asserted-by":"crossref","first-page":"E506","DOI":"10.1503\/cmaj.121232","article-title":"Peripheral edema with pregabalin","volume":"185","author":"Gallagher","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.jphs.2016.01.002_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF02977784","article-title":"The effect of MDR1 G2677T\/A polymorphism on pharmacokinetics of gabapentin in healthy Korean subjects","volume":"30","author":"Kang","year":"2007","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.jphs.2016.01.002_bib8","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1124\/jpet.104.082255","article-title":"Mediation of highly concentrative uptake of pregabalin by L-type amino acid transport in Chinese hamster ovary and Caco-2 cells","volume":"313","author":"Su","year":"2005","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2016.01.002_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2016.01.002_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1744-8069-4-52","article-title":"Prolonged gabapentin analgesia in an experimental mouse model of fibromyalgia","volume":"4","author":"Nishiyori","year":"2008","journal-title":"Mol Pain"},{"key":"10.1016\/j.jphs.2016.01.002_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0304-3959(98)00045-1","article-title":"Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates","volume":"76","author":"Malmberg","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2016.01.002_bib12","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1523\/JNEUROSCI.5541-09.2010","article-title":"Epigenetic gene silencing underlies C-fiber dysfunctions in neuropathic pain","volume":"30","author":"Uchida","year":"2010","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.jphs.2016.01.002_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2009.01.014","article-title":"Oral pregabalin reverses cold allodynia in two distinct\u00a0models of peripheral neuropathic pain","volume":"605","author":"Gustafsson","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2016.01.002_bib14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/jpet.114.222414","article-title":"Donepezil reverses intermittent stress-induced generalized chronic pain syndrome in mice","volume":"353","author":"Mukae","year":"2015","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2016.01.002_bib15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.pain.2010.12.014","article-title":"Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states","volume":"152","author":"Boroujerdi","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.jphs.2016.01.002_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.pain.2006.06.001","article-title":"Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia)","volume":"124","author":"Vierck","year":"2006","journal-title":"Pain"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861316000037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861316000037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T05:57:41Z","timestamp":1537077461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861316000037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1347861316000037"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2016.01.002","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P-glycoprotein inhibitors improve effective dose and time of pregabalin to inhibit intermittent cold stress-induced central pain","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2016.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}